{"id":78083,"date":"2024-07-09T12:02:20","date_gmt":"2024-07-09T10:02:20","guid":{"rendered":"https:\/\/cri1149.mlcom-dev.net\/publication\/bulevirtide-combined-with-pegylated-interferon-for-chronic-hepatitis-d\/"},"modified":"2025-12-05T17:20:02","modified_gmt":"2025-12-05T16:20:02","slug":"bulevirtide-combined-with-pegylated-interferon-for-chronic-hepatitis-d","status":"publish","type":"publication","link":"https:\/\/cri1149.mlcom-dev.net\/en\/publication\/bulevirtide-combined-with-pegylated-interferon-for-chronic-hepatitis-d\/","title":{"rendered":"Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false},"class_list":["post-78083","publication","type-publication","status-publish","hentry"],"acf":{"numero_de_publication":"New England Journal of Medecine","date_de_publication":"20240606","numero_doi":"10.1056\/NEJMoa2314134","equipe":[331],"auteurs-liste":[{"texte_libre":false,"auteur-lien":78525,"auteur-text":""},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Vladimir Chulanov"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Pietro Lampertico"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Heiner Wedemeyer"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Adrian Streinu-Cercel"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Victor P\u00e2ntea"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Stefan Lazar"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Gheorghe Placinta"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"George S Gherlan"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Pavel Bogomolov"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Tatyana Stepanova"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Viacheslav Morozov"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Vladimir Syutkin"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Olga Sagalova"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Dmitry Manuilov"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Renee-Claude Mercier "},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Lei Ye"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Ben L Da"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Grace Chee"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Audrey H Lau"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Anu Osinusi"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Marc Bourliere"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Vlad Ratziu"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Stanislas Pol"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Marie-No\u00eblle Hilleret"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Fabien Zoulim"},{"texte_libre":true,"auteur-lien":null,"auteur-text":"Samuel Didier"}],"auteurs-manuel":"","liens_externes":[{"url":"https:\/\/www-nejm-org.proxy.insermbiblio.inist.fr\/doi\/full\/10.1056\/NEJMoa2314134"}],"liens":null,"paragraphe":"","paragraphe_en":"","documents":[{"document":79567}]},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D - CRI<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D - CRI\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cri1149.mlcom-dev.net\/publication\/lassociation-du-bulevirtide-a-linterferon-pegyle-comme-traitement-de-duree-definie-pour-lhepatite-chronique-delta\/\" \/>\n<meta property=\"og:site_name\" content=\"CRI\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CRI-Centre-de-recherche-sur-linflammation-100116118884153\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-05T16:20:02+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cri1149.mlcom-dev.net\/publication\/lassociation-du-bulevirtide-a-linterferon-pegyle-comme-traitement-de-duree-definie-pour-lhepatite-chronique-delta\/\",\"url\":\"https:\/\/cri1149.mlcom-dev.net\/publication\/lassociation-du-bulevirtide-a-linterferon-pegyle-comme-traitement-de-duree-definie-pour-lhepatite-chronique-delta\/\",\"name\":\"Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D - CRI\",\"isPartOf\":{\"@id\":\"https:\/\/cri1149.mlcom-dev.net\/#website\"},\"datePublished\":\"2024-07-09T10:02:20+00:00\",\"dateModified\":\"2025-12-05T16:20:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cri1149.mlcom-dev.net\/publication\/lassociation-du-bulevirtide-a-linterferon-pegyle-comme-traitement-de-duree-definie-pour-lhepatite-chronique-delta\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cri1149.mlcom-dev.net\/publication\/lassociation-du-bulevirtide-a-linterferon-pegyle-comme-traitement-de-duree-definie-pour-lhepatite-chronique-delta\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cri1149.mlcom-dev.net\/publication\/lassociation-du-bulevirtide-a-linterferon-pegyle-comme-traitement-de-duree-definie-pour-lhepatite-chronique-delta\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/cri1149.mlcom-dev.net\/en\/cri-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications\",\"item\":\"https:\/\/cri1149.mlcom-dev.net\/publications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cri1149.mlcom-dev.net\/#website\",\"url\":\"https:\/\/cri1149.mlcom-dev.net\/\",\"name\":\"CRI - Centre de Recherche sur l'Inflammation\",\"description\":\"Centre de Recherche sur l&#039;Inflammation\",\"publisher\":{\"@id\":\"https:\/\/cri1149.mlcom-dev.net\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cri1149.mlcom-dev.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cri1149.mlcom-dev.net\/#organization\",\"name\":\"CRI1149\",\"url\":\"https:\/\/cri1149.mlcom-dev.net\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cri1149.mlcom-dev.net\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cri1149.mlcom-dev.net\/wp-content\/uploads\/2014\/11\/8.4.2014-logo-CRI.jpg\",\"contentUrl\":\"https:\/\/cri1149.mlcom-dev.net\/wp-content\/uploads\/2014\/11\/8.4.2014-logo-CRI.jpg\",\"width\":215,\"height\":176,\"caption\":\"CRI1149\"},\"image\":{\"@id\":\"https:\/\/cri1149.mlcom-dev.net\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/CRI-Centre-de-recherche-sur-linflammation-100116118884153\",\"https:\/\/www.linkedin.com\/company\/cri-centre-de-recherche-sur-l-inflammation\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D - CRI","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D - CRI","og_url":"https:\/\/cri1149.mlcom-dev.net\/publication\/lassociation-du-bulevirtide-a-linterferon-pegyle-comme-traitement-de-duree-definie-pour-lhepatite-chronique-delta\/","og_site_name":"CRI","article_publisher":"https:\/\/www.facebook.com\/CRI-Centre-de-recherche-sur-linflammation-100116118884153","article_modified_time":"2025-12-05T16:20:02+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cri1149.mlcom-dev.net\/publication\/lassociation-du-bulevirtide-a-linterferon-pegyle-comme-traitement-de-duree-definie-pour-lhepatite-chronique-delta\/","url":"https:\/\/cri1149.mlcom-dev.net\/publication\/lassociation-du-bulevirtide-a-linterferon-pegyle-comme-traitement-de-duree-definie-pour-lhepatite-chronique-delta\/","name":"Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D - CRI","isPartOf":{"@id":"https:\/\/cri1149.mlcom-dev.net\/#website"},"datePublished":"2024-07-09T10:02:20+00:00","dateModified":"2025-12-05T16:20:02+00:00","breadcrumb":{"@id":"https:\/\/cri1149.mlcom-dev.net\/publication\/lassociation-du-bulevirtide-a-linterferon-pegyle-comme-traitement-de-duree-definie-pour-lhepatite-chronique-delta\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cri1149.mlcom-dev.net\/publication\/lassociation-du-bulevirtide-a-linterferon-pegyle-comme-traitement-de-duree-definie-pour-lhepatite-chronique-delta\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cri1149.mlcom-dev.net\/publication\/lassociation-du-bulevirtide-a-linterferon-pegyle-comme-traitement-de-duree-definie-pour-lhepatite-chronique-delta\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/cri1149.mlcom-dev.net\/en\/cri-home\/"},{"@type":"ListItem","position":2,"name":"Publications","item":"https:\/\/cri1149.mlcom-dev.net\/publications\/"},{"@type":"ListItem","position":3,"name":"Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D"}]},{"@type":"WebSite","@id":"https:\/\/cri1149.mlcom-dev.net\/#website","url":"https:\/\/cri1149.mlcom-dev.net\/","name":"CRI - Centre de Recherche sur l'Inflammation","description":"Centre de Recherche sur l&#039;Inflammation","publisher":{"@id":"https:\/\/cri1149.mlcom-dev.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cri1149.mlcom-dev.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cri1149.mlcom-dev.net\/#organization","name":"CRI1149","url":"https:\/\/cri1149.mlcom-dev.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cri1149.mlcom-dev.net\/#\/schema\/logo\/image\/","url":"https:\/\/cri1149.mlcom-dev.net\/wp-content\/uploads\/2014\/11\/8.4.2014-logo-CRI.jpg","contentUrl":"https:\/\/cri1149.mlcom-dev.net\/wp-content\/uploads\/2014\/11\/8.4.2014-logo-CRI.jpg","width":215,"height":176,"caption":"CRI1149"},"image":{"@id":"https:\/\/cri1149.mlcom-dev.net\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CRI-Centre-de-recherche-sur-linflammation-100116118884153","https:\/\/www.linkedin.com\/company\/cri-centre-de-recherche-sur-l-inflammation\/"]}]}},"post_type":"publication","author_name":"","_links":{"self":[{"href":"https:\/\/cri1149.mlcom-dev.net\/en\/wp-json\/wp\/v2\/publication\/78083","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cri1149.mlcom-dev.net\/en\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/cri1149.mlcom-dev.net\/en\/wp-json\/wp\/v2\/types\/publication"}],"acf:term":[{"embeddable":true,"taxonomy":"equipes","href":"https:\/\/cri1149.mlcom-dev.net\/en\/wp-json\/wp\/v2\/equipes\/331"}],"wp:attachment":[{"href":"https:\/\/cri1149.mlcom-dev.net\/en\/wp-json\/wp\/v2\/media?parent=78083"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}